We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Novasep Opens Kilo Lab Extension at US Facility
Product News

Novasep Opens Kilo Lab Extension at US Facility

Novasep Opens Kilo Lab Extension at US Facility
Product News

Novasep Opens Kilo Lab Extension at US Facility


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Novasep Opens Kilo Lab Extension at US Facility"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Novasep has announced that it has finalized the set-up of its new synthesis laboratory and kilo lab at its US facility. Production of kilogram scale batches of synthetic molecules for biological testing and preclinical trials has begun according to schedule. “Drug developers in the US are responding positively to our extended CMO services that support their early stage programs," said Andrew Brennan, general manager at Novasep’s US operations.

“The opening day was held together with our customers and Novasep’s scientific board member Prof Alois Fürstner, who made an inspiring presentation on catalysis. This was a great way to kick-off the opening of our new lab.” “This extension is part of our 'Back to Basics' strategic plan,” said Thierry Van Nieuwenhove, Synthesis BU president.

“The proximity to our US experts will help to secure and speed up our customers’ projects. And beyond the technical expertise of our team, the trusted partnerships that Novasep is building with US companies will promote future development and commercial supply agreements to keep up with the fast growing US pharmaceutical market.”
 
The US facility in Boothwyn, PA, is equipped with jacketed reactors ranging from 100mL to 50L in size and with a 35L filter dryer for isolation of kilogram quantities of compound. The laboratory extension features all the necessary equipment for standard and cryogenic chemistry.

In terms of purification services, it provides North American customers with the complete portfolio of Novasep preparative chromatography technologies, such as HPLC (Hipersep®) and SFC (Supersep®). In addition, it has all the required analytical tools for process research and development (HPLC, HPLC/MS, GC, GC Headspace, UPLC, UPLC/MS, etc.), including a calorimetric reactor for preliminary process safety testing.

Advertisement